Health Care • Medical/Nursing Services
$19.65 ▲ +0.47
(+2.45%)
MKT CAP: $1.20B • VOL: 620.1K
52W L $10 52W H $26
OMDA // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $260.2M | $169.8M | $122.8M |
| YoY Revenue Growth % | +53.2% | +38.3% | — |
| Gross Profit | $170.9M | $102.9M | — |
| Gross Margin % | 65.7% | 60.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$12.0M | -$43.7M | -$66.0M |
| Operating Margin % | -4.6% | -25.7% | -53.8% |
| Net Income (GAAP) | -$12.8M | -$47.1M | -$67.5M |
| EBITDA (Normalized) | -$10.9M | -$43.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $18.3M | -$34.2M | -$49.7M |
| Capital Expenditures (CapEx) | $1.3M | $596.0K | — |
| Free Cash Flow (FCF) | $16.9M | -$34.8M | -$49.7M |
| FCF Margin % | 6.5% | -20.5% | -40.5% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $222.0M | $76.4M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $229.7M | -$384.4M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR OMDA.